Literature DB >> 23042343

Lethal H5N1 influenza viruses are not resistant to interferon action in human, simian, porcine or chicken cells.

John M Ngunjiri, Kareem N Mohni, Margaret J Sekellick, Stacey Schultz-Cherry, Robert G Webster, Philip I Marcus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23042343     DOI： 10.1038/nm.2879

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

1.  Transient resistance of influenza virus to interferon action attributed to random multiple packaging and activity of NS genes.

Authors:  M J Sekellick; S A Carra; A Bowman; D A Hopkins; P I Marcus
Journal:  J Interferon Cytokine Res       Date:  2000-11       Impact factor: 2.607

2.  In vitro analysis of virus particle subpopulations in candidate live-attenuated influenza vaccines distinguishes effective from ineffective vaccines.

Authors:  Philip I Marcus; John M Ngunjiri; Margaret J Sekellick; Leyi Wang; Chang-Won Lee
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

3.  Airborne transmission of influenza A/H5N1 virus between ferrets.

Authors:  Sander Herfst; Eefje J A Schrauwen; Martin Linster; Salin Chutinimitkul; Emmie de Wit; Vincent J Munster; Erin M Sorrell; Theo M Bestebroer; David F Burke; Derek J Smith; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Science       Date:  2012-06-22       Impact factor: 47.728

Review 4.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

5.  Mycoplasmas produce double-stranded ribonuclease.

Authors:  P I Marcus; I Yoshida
Journal:  J Cell Physiol       Date:  1990-06       Impact factor: 6.384

6.  Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo.

Authors:  Emanuel Haasbach; Karoline Droebner; Annette B Vogel; Oliver Planz
Journal:  J Interferon Cytokine Res       Date:  2011-02-16       Impact factor: 2.607

7.  Early control of H5N1 influenza virus replication by the type I interferon response in mice.

Authors:  Kristy J Szretter; Shivaprakash Gangappa; Jessica A Belser; Hui Zeng; Hualan Chen; Yumiko Matsuoka; Suryaprakash Sambhara; David E Swayne; Terrence M Tumpey; Jacqueline M Katz
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

8.  Lethal H5N1 influenza viruses escape host anti-viral cytokine responses.

Authors:  Sang Heui Seo; Erich Hoffmann; Robert G Webster
Journal:  Nat Med       Date:  2002-08-26       Impact factor: 53.440

9.  NS1 proteins of avian influenza A viruses can act as antagonists of the human alpha/beta interferon response.

Authors:  A Hayman; S Comely; A Lackenby; L C S Hartgroves; S Goodbourn; J W McCauley; W S Barclay
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

10.  Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets.

Authors:  Masaki Imai; Tokiko Watanabe; Masato Hatta; Subash C Das; Makoto Ozawa; Kyoko Shinya; Gongxun Zhong; Anthony Hanson; Hiroaki Katsura; Shinji Watanabe; Chengjun Li; Eiryo Kawakami; Shinya Yamada; Maki Kiso; Yasuo Suzuki; Eileen A Maher; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Nature       Date:  2012-05-02       Impact factor: 49.962
View more
  8 in total

1.  Influenza A Virus Protein PA-X Contributes to Viral Growth and Suppression of the Host Antiviral and Immune Responses.

Authors:  Tsuyoshi Hayashi; Leslie A MacDonald; Toru Takimoto
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

2.  Changes in the NS1 gene of avian influenza viruses isolated in Thailand affect expression of type I interferon in primary chicken embryonic fibroblast cells.

Authors:  Chutamas Thepmalee; Phanchana Sanguansermsri; Naratchala Suwanankhon; Chanpen Chamnanpood; Pornchai Chamnanpood; Sutatip Pongcharoen; Pannika R Niumsap; Damratsamon Surangkul; Donruedee Sanguansermsri
Journal:  Indian J Virol       Date:  2013-08-28

3.  In vivo assessment of NS1-truncated influenza virus with a novel SLSYSINWRH motif as a self-adjuvanting live attenuated vaccine.

Authors:  John M Ngunjiri; Ahmed Ali; Prosper Boyaka; Philip I Marcus; Chang-Won Lee
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

4.  Highly Pathogenic H5N1 Influenza A Virus Spreads Efficiently in Human Primary Monocyte-Derived Macrophages and Dendritic Cells.

Authors:  Veera Westenius; Sanna M Mäkelä; Ilkka Julkunen; Pamela Österlund
Journal:  Front Immunol       Date:  2018-07-17       Impact factor: 7.561

Review 5.  Twenty-five years of type I interferon-based treatment: a critical analysis of its therapeutic use.

Authors:  Guido Antonelli; Carolina Scagnolari; Federica Moschella; Enrico Proietti
Journal:  Cytokine Growth Factor Rev       Date:  2014-12-30       Impact factor: 7.638

6.  Novel avian influenza A (H7N9) virus induces impaired interferon responses in human dendritic cells.

Authors:  Veera Arilahti; Sanna M Mäkelä; Janne Tynell; Ilkka Julkunen; Pamela Österlund
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

7.  Impact of Individual Viral Gene Segments from Influenza A/H5N8 Virus on the Protective Efficacy of Inactivated Subtype-Specific Influenza Vaccine.

Authors:  Yassmin Moatasim; Ahmed Kandeil; Ahmed Mostafa; Omnia Kutkat; Mohamed El Sayes; Ahmed N El Taweel; Maha AlKhazindar; Elsayed T AbdElSalam; Rabeh El-Shesheny; Ghazi Kayali; Mohamed A Ali
Journal:  Pathogens       Date:  2021-03-19

8.  Infiltration of inflammatory macrophages and neutrophils and widespread pyroptosis in lung drive influenza lethality in nonhuman primates.

Authors:  Jacqueline Corry; Gwenddolen Kettenburg; Amit A Upadhyay; Megan Wallace; Michelle M Marti; Elizabeth R Wonderlich; Stephanie J Bissel; Kyndal Goss; Timothy J Sturgeon; Simon C Watkins; Douglas S Reed; Steven E Bosinger; Simon M Barratt-Boyes
Journal:  PLoS Pathog       Date:  2022-03-10       Impact factor: 6.823
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.